Alnylam Pharmaceuticals Inc (ALNY) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

Data del prossimo reportMay 2, 2024

Stimato per Q1 24:$-1.30

Cambiamenti implicati per il Q4 23:+18.18%

Cambiamenti implicati per il Q1 22:-35.00%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q4 23	Feb 15, 2024	$-1.1 / $-1.2	$0.1 / 8.33%
Q3 23	Nov 2, 2023	$1.15 / $-1.61	$2.76 / 171.43%
Q2 23	Aug 3, 2023	$-2.21 / $-1.72	$-0.49 / -28.49%
Q1 23	May 4, 2023	$-1.4 / $-1.97	$0.57 / 28.93%
Q4 22	Feb 23, 2023	$-1.68 / $-2.13	$0.45 / 21.13%
Q3 22	Oct 27, 2022	$-3.32 / $-1.86	$-1.46 / -78.49%
Q2 22	Jul 28, 2022	$-2.29 / $-1.62	$-0.67 / -41.36%
Q1 22	Apr 28, 2022	$-2 / $-1.93	$-0.07 / -3.63%

Fornitori di Dati: Xignite Logo